Answers are grounded in this paper and cite their sources.
Objective: D-dimer testing is commonly used in emergency departments (EDs) to rule out thromboembolic events. However, elevated D-dimer levels may also be associated with an increased risk of mortality, independent of thromboembolism. Methods: This prospective observational study enrolled acutely ill medical ED patients. D-dimer measurements were conducted as part of biobanking at ED presentation. Survival at 30, 90, and 360 days was analyzed in relation to D-dimer, and Receiver operating characteristic (ROC) curves and logistic regressions were performed. Among discharged patients, 360-day mortality was 9.2% with elevated D-dimer vs. 0.7% with normal values (log-rank p < 0.001).The ROC-derived optimal cut-off for both time points was 0.75 μg/mL (AUC 0.82 and 0.76 for 30- and 360-day mortality). Multivariable analysis adjusted for age, BMI, and comorbidities yielded elevated D-dimer to remain an independent predictor of mortality. Conclusion: In unselected ED patients, D-dimer independently predicts 30- and 360-day mortality. Beyond its diagnostic role for VTE, an elevated D-dimer-particularly in patients with no VTE and discharge from the ED-identifies individuals at increased short- and long-term risk. Incorporating D-dimer (e.g., ≥ 0.75 μg/mL) into routine risk stratification may support targeted follow-up and post-discharge management.
No takes yet. Share an insight, caveat, or question.
Kornfehl et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: